Loading clinical trials...
Loading clinical trials...
This is a prospective, investigator-initiated, multi-center, open label and post-market registry, enrolling patients with atherosclerotic coronary artery disease, scheduled for CABG with at least one ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cardiocentro Ticino
NCT07660419 · Coronary Artery Disease (CAD), Coronary Stenosis
NCT06779630 · Coronary Artery Disease
NCT07565805 · Coronary Artery Disease (CAD)
NCT07560436 · Heart Failure With Preserved Ejection Fraction (HFPEF), Coronary Artery Disease
NCT07324720 · Coronary Artery Disease
Medical University of Innsbruck
Innsbruck
AKH (Vienna General Hospital)
Vienna
Floridsdorf Clinic
Vienna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions